Star Health Insu

Why is Star Health & Allied Insurance Company Ltd falling/rising?

As of 08-Aug, the stock price of Star Health & Allied Insurance Company Ltd is declining, currently at 569.95, with a total drop of 6.84% over the last six days. Despite strong long-term growth, recent performance has been negative, marked by decreased investor participation and underperformance against the benchmark Sensex.

As of 08-Aug, the stock price of Star Health & Allied Insurance Company Ltd is falling, currently at 569.95, reflecting a decrease of 3.45 (-0.6%). This decline is part of a broader trend, as the stock has been losing value for the last six consecutive days, resulting in a total drop of 6.84% during this period. <BR><BR>In terms of performance relative to the market, the stock has underperformed against the benchmark Sensex over various time frames, including a 5.14% decline over the past week and a 3.38% drop over the past month. Although the stock has shown strong long-term growth with a 25.26% increase year-to-date and a 31.23% rise over the past year, the recent short-term performance has been negative.<BR><BR>Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 58.19% compared to the 5-day average, indicating reduced trading interest. While the stock remains liquid enough for trading, the current moving averages suggest that it is lower than the 5-day and 20-day averages, which may contribute to the downward pressure on the stock price. <BR><BR>Overall, despite its strong fundamentals and historical performance, the recent trends in price movement and investor activity are contributing to the stock's current decline.

Which are the latest news on Star Health Insu?

Are Star Health & Allied Insurance Company Ltd latest results good or bad?

Star Health & Allied Insurance Company Ltd's latest results are positive, showing a net profit of ₹549.73 crores for Q1 FY27, a significant recovery from a previous loss, and a 13.39% increase in premium income. However, concerns about high valuation and modest return on equity suggest investors should remain cautious about the sustainability of this growth.

Star Health & Allied Insurance Company Ltd's latest results indicate a strong turnaround, marking a significant improvement in its financial performance. For Q1 FY27, the company reported a net profit of ₹549.73 crores, which is a remarkable recovery from a loss of ₹55.40 crores in the previous quarter. This represents a year-on-year growth of 25.48%.<BR><BR>Additionally, the company achieved premium income of ₹4,917.20 crores, reflecting a 13.39% increase compared to the same quarter last year. The operating margin improved significantly to 15.24%, up 1,150 basis points quarter-on-quarter, indicating enhanced operational efficiency and better claims management.<BR><BR>While these results are positive and suggest a recovery trajectory, there are concerns regarding the company's valuation. Star Health trades at a high price-to-earnings ratio of 64 times trailing earnings and a price-to-book value of 4.76, which raises questions about the sustainability of this growth. Furthermore, the average return on equity remains modest at 7.56%, which is below the typical threshold expected from quality insurance companies.<BR><BR>In summary, while the latest results are good, showcasing a strong recovery and improved profitability, the high valuation and modest return on equity suggest that investors should remain cautious and monitor the company's ability to sustain this performance over time.

Should I buy, sell or hold Star Health & Allied Insurance Company Ltd?

What does Star Health Insu do?

Star Health and Allied Insurance Company Ltd specializes in health insurance and was established in 2005. As of March 2026, it reported net sales of ₹4,327 Cr and a net profit of ₹111 Cr, with a market cap of ₹30,932 Cr.

Overview: <BR>Star Health and Allied Insurance Company Ltd operates in the insurance industry, specifically focusing on health insurance, and is categorized as a small-cap company.<BR><BR>History: <BR>The company was incorporated on 17 June 2005 in Chennai and received regulatory approval to commence health insurance operations on 16 March 2006. The latest quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 4,327 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 111 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 30,932 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 55.00 <BR>Industry P/E: 20 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.06 <BR>Return on Equity: 7.48% <BR>Price to Book: 4.14<BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

How big is Star Health Insu?

As of 10th June, Star Health & Allied Insurance Company Ltd has a market capitalization of 30,932.00 Cr, with Net Sales of 16,596.68 Cr and a Net Profit of 556.98 Cr reported in the latest 4 quarters. Shareholder's Funds are 7,059.17 Cr and Total Assets are 20,433.42 Cr as of March 2025.

As of 10th June, Star Health & Allied Insurance Company Ltd has a market capitalization of 30,932.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest 4 quarters, the company reported Net Sales of 16,596.68 Cr and a Net Profit of 556.98 Cr.<BR><BR>For the latest annual period ending March 2025, Shareholder's Funds amounted to 7,059.17 Cr, while Total Assets were reported at 20,433.42 Cr.

Who are in the management team of Star Health Insu?

The management team of Star Health Insurance includes Anand Shankar Roy (Managing Director & CEO), along with several nominees and independent directors, such as Rohit Bhasin and Anisha Motwani, as well as Jayashree Sethuraman as Company Secretary & Compliance Officer. This diverse team provides strong leadership and expertise to the company.

The management team of Star Health Insurance includes the following individuals:<BR><BR>1. **Anand Shankar Roy** - Managing Director & CEO<BR>2. **Sumir Chadha** - Nominee<BR>3. **Deepak Ramineedi** - Nominee<BR>4. **Utpal Seth** - Nominee<BR>5. **Rohit Bhasin** - Independent Director<BR>6. **Anisha Motwani** - Independent Director<BR>7. **Berjis M Desai** - Independent Director<BR>8. **Rajeev Kumar Agarwal** - Independent Director<BR>9. **Rajni Sekhri Sibal** - Independent Director<BR>10. **Jayashree Sethuraman** - Company Secretary & Compliance Officer<BR><BR>This team brings a mix of expertise and leadership to the company.

Who are the peers of the Star Health Insu?

Star Health Insu's peers include HDFC Life Insurance, ICICI Lombard, ICICI Prudential Life, Max Financial, Go Digit General, New India Assurance, Niva Bupa Health, and Medi Assist Services. Star Health Insu has the highest 1-year return at 12.98%, while New India Assurance has the lowest at -25.60%.

Peers: The peers of Star Health Insu are HDFC Life Insur., ICICI Lombard, ICICI Pru Life, General Insuranc, Max Financial, Go Digit General, New India Assura, Niva Bupa Health, and Medi Assist Ser.<BR><BR>Quality Snapshot: Excellent management risk is observed at HDFC Life Insur., ICICI Lombard, and Go Digit General, while Average management risk is found at ICICI Pru Life, General Insuranc, Max Financial, Star Health Insu, and Niva Bupa Health. Below Average management risk is noted for New India Assura. In terms of growth, Good growth is seen at Go Digit General and Niva Bupa Health, while Average growth is observed at HDFC Life Insur., ICICI Lombard, General Insuranc, and Medi Assist Ser., and Below Average growth is present at ICICI Pru Life, Max Financial, Star Health Insu, and New India Assura. All peers have an Excellent capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Star Health Insu at 12.98%, while the lowest is New India Assura at -25.60%. Star Health Insu's return is significantly higher than that of New India Assura. Additionally, the six-month return is negative for ICICI Pru Life, Max Financial, Go Digit General, New India Assura, and Medi Assist Ser.

Is Star Health Insu technically bullish or bearish?

As of December 1, 2025, the trend is mildly bullish due to positive short-term signals, but mixed longer-term indicators suggest caution.

As of 1 December 2025, the technical trend has changed from bullish to mildly bullish. The current stance is mildly bullish, driven by the weekly MACD being bullish and the daily moving averages indicating a mildly bullish trend. However, the monthly MACD is mildly bearish, and the KST shows a bearish signal on the monthly timeframe. The Bollinger Bands are mildly bullish on the weekly but sideways on the monthly, indicating some indecision. Overall, while there are positive signals in the short term, the mixed signals in the longer timeframes suggest caution.

How has been the historical performance of Star Health Insu?

Star Health Insu has shown significant growth, with net sales increasing from 4,626.63 Cr in Mar'21 to 14,822.20 Cr in Mar'25, and profit after tax improving from a loss of 1,085.71 Cr to a profit of 645.86 Cr in the same period. Despite fluctuations in operating profit, total assets rose to 20,433.42 Cr in Mar'25, and cash flow from operations turned positive with a net inflow of 223.00 Cr.

Answer:<BR>The historical performance of Star Health Insu shows a significant growth trajectory in net sales and total operating income over the years, with net sales increasing from 4,626.63 Cr in Mar'21 to 14,822.20 Cr in Mar'25. Other operating income also rose from 423.69 Cr in Mar'21 to 1,279.03 Cr in Mar'25, contributing to a total operating income of 16,101.23 Cr in Mar'25, up from 5,050.32 Cr in Mar'21. Despite this growth, the operating profit (PBDIT) has fluctuated, peaking at 1,128.85 Cr in Mar'24 before declining to 861.05 Cr in Mar'25. Profit after tax has shown improvement, moving from a loss of 1,085.71 Cr in Mar'21 to a profit of 645.86 Cr in Mar'25. The company's total assets have also increased significantly, reaching 20,433.42 Cr in Mar'25 from 5,980.00 Cr in Mar'20, while total liabilities rose to 20,433.42 Cr in Mar'25 from 5,980.00 Cr in Mar'20. Cash flow from operating activities has been positive, with a net cash inflow of 223.00 Cr in Mar'25, compared to a net outflow of 1,221.00 Cr in Mar'22.<BR><BR>Breakdown:<BR>Star Health Insu has demonstrated robust growth in its financial metrics over the years. Net sales surged from 4,626.63 Cr in Mar'21 to 14,822.20 Cr in Mar'25, reflecting a strong demand for its services. Other operating income also increased significantly, contributing to a total operating income that rose from 5,050.32 Cr in Mar'21 to 16,101.23 Cr in Mar'25. However, the operating profit (PBDIT) experienced fluctuations, with a peak in Mar'24 at 1,128.85 Cr, followed by a decline to 861.05 Cr in Mar'25. The profit after tax improved notably, transitioning from losses in previous years to a profit of 645.86 Cr in Mar'25. The total assets of the company expanded impressively, reaching 20,433.42 Cr in Mar'25, while total liabilities mirrored this growth. Cash flow from operating activities remained positive, indicating a healthy operational performance, with a net cash inflow of 223.00 Cr in Mar'25, contrasting with the challenges faced in earlier years.

Is Star Health Insu overvalued or undervalued?

As of October 29, 2025, Star Health Insurance is considered very expensive and overvalued with a PE ratio of 53.01, significantly higher than its peers, and has underperformed the market with a 1-year return of -10.85%.

As of 29 October 2025, the valuation grade for Star Health Insurance has moved from expensive to very expensive. This indicates a significant deterioration in its valuation outlook. The company is currently assessed as overvalued, with a PE ratio of 53.01, a Price to Book Value of 4.00, and an EV to EBIT of 13.77. These ratios suggest that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, Bajaj Finance has a PE ratio of 37.96 and an EV to EBITDA of 20.16, while Life Insurance boasts a much lower PE ratio of 11.8 and an EV to EBITDA of 9.21, highlighting the expensive nature of Star Health Insurance relative to its competitors. Additionally, the company's recent stock performance has been underwhelming, with a 1-year return of -10.85% compared to the Sensex's 5.76%, further reinforcing the perception of overvaluation.

Who are the top shareholders of the Star Health Insu?

The top shareholder of Star Health Insurance is Safecrop Investments India LLP, holding 40.23%. Other significant shareholders include 18 mutual fund schemes with 9.45%, 177 foreign institutional investors with 18.68%, and individual investors with 5.57%.

The top shareholders of Star Health Insurance include a mix of promoters, institutional investors, and individual shareholders. The largest shareholder is Safecrop Investments India LLP, which holds 40.23% of the company. <BR><BR>In terms of institutional holdings, 18 mutual fund schemes collectively own 9.45%, while 177 foreign institutional investors (FIIs) hold 18.68%. The highest public shareholder is ICICI Prudential Pharma Healthcare and Diagnostics Fund, which has a stake of 4.8%. Additionally, individual investors collectively hold 5.57% of the company. <BR><BR>This diverse ownership structure reflects a strong interest from both domestic and international investors.

When is the next results date for Star Health Insu?

No Upcoming Board Meetings

Has Star Health Insu declared dividend?

No Dividend History Available